NewAmsterdam Pharma Company N.V. Share Price Deutsche Boerse AG
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.4 EUR | +5.75% | +5.45% | +77.55% |
Sales 2024 * | 8.6M 9.32M 777M | Sales 2025 * | 6.3M 6.82M 569M | Capitalization | 1.67B 1.8B 151B |
---|---|---|---|---|---|
Net income 2024 * | -209M -226M -18.88B | Net income 2025 * | -139M -151M -12.56B | EV / Sales 2024 * | 194 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 265 x |
P/E ratio 2024 * |
-7.94
x | P/E ratio 2025 * |
-12.4
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 day | +6.03% | ||
1 week | +5.45% | ||
Current month | +7.41% | ||
1 month | -7.45% | ||
3 months | -5.95% | ||
6 months | +100.00% | ||
Current year | +77.55% |
Date | Price | Change |
---|---|---|
12/24/12 | 17.4 | 0.00% |
11/24/11 | 17.4 | +1.75% |
10/24/10 | 17.1 | -0.58% |
07/24/07 | 17.2 | +2.38% |
06/24/06 | 16.8 | +1.82% |
Delayed Quote Deutsche Boerse AG, June 12, 2024 at 06:59 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.49% | 124B | |
+15.79% | 109B | |
-6.21% | 23.84B | |
+2.53% | 22.42B | |
-13.90% | 17.5B | |
-11.30% | 16.61B | |
-41.64% | 16.43B | |
+2.87% | 13.4B | |
+26.91% | 11.47B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock